James Dow
Challenges and Benefits of Patient-Based Phase I Trials
May 05 by Pharma IQPharma IQ held a Q&A session with Dr. James Dow, Director of Clinical Pharmacology & DMPK, (OSI) Prosidion to gain a few insights into phase I clinical development and patient-bas...